Steven C Degon

Title: Steven C Degon: Innovator in Fc-Interferon-Beta Fusion Proteins

Introduction

Steven C Degon is a notable inventor based in Hampton, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that enhance therapeutic efficacy.

Latest Patents

Steven C Degon holds a patent for the "Stabilization of Fc-interferon-beta fusion proteins." This patent discloses Fc-interferon-beta (Fc-IFN-β) fusion proteins and nucleic acid molecules encoding them. The Fc-IFN-β fusion proteins include variants of the interferon-beta (IFN-β) protein that are altered to achieve enhanced biological activity, prolonged circulating half-life, and greater solubility. The patent also outlines methods for producing these fusion proteins and their applications in treating diseases and conditions alleviated by the administration of interferon-beta. He has 1 patent to his name.

Career Highlights

Steven C Degon is associated with Merck Patent GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on improving the therapeutic potential of interferon-beta through advanced protein engineering techniques.

Collaborations

Some of his notable coworkers include Stephen D Gillies and Nigel John Watkins, who have collaborated with him on various projects related to biotechnology and pharmaceutical innovations.

Conclusion

Steven C Degon is a prominent figure in the field of biotechnology, with a focus on enhancing the efficacy of therapeutic proteins. His work on Fc-interferon-beta fusion proteins represents a significant advancement in the treatment of diseases, showcasing his innovative spirit and dedication to improving healthcare solutions.